Category: DaVita Inc.
B. Braun inked a supply deal for Davita's dialysis products.
B. Braun Medical said it's entered an agreement with DaVita to provide its Dialog+ dialysis equipment to fill a portion of DaVita's product requirement.
Bethlehem, Pa.-based Braun has been a leader in the dialysis field for years and has a long-standing relationship with DaVita. The Dialog+ system allows patients to have the greatest number of possible configurations for individual treatment.
CVRx adds $12 million from DaVita HealthCare and others to its $42 million Series F round.
CVRx said it added $12 million from DaVita HealthCare, Ysios Capital and others to its Series F funding round, taking the total for the round to $42 million.
The Minneapolis-based company is planning to use the money to advance clinical trials and expand its international commercial footprint, according to a press release. CVRx developed the Barostim Neo, a pacemaker-like device designed to treat hypertension.
Medical device makers DaVita and Fresenius suffer Wall Street losses amid Medicare's proposal to cut about 9% from dialysis reimbursements.
Updated July 2, 2013, at 3:45 p.m. with comment from NxStage Medical.
Updated July 2, 2013, at 5 p.m. with comment from Fresenius.
Dialysis technology makers slid hard today after the Center for Medicare & Medicaid Services proposed a reimbursement decrease of more than 9% for 2014.
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
Eden Prairie, Minn., and Sydney-based medical device company Sunshine Heart (ASX:SHC) is looking to raise funds in a $25.5 million equity funding round, according to document filed with the SEC earlier this month.
Hamilton Thorne puts a new man in the corner office after his two-year term as company president.
Laser-based lab equipment maker Hamilton Thorne Inc. (TSX-V: HTL) has named company president David Wolf as CEO. Wolf takes over the post from company co-founder Meg Spencer, who will remain with Hamilton Thorne as chairman of the board and a chief strategic advisor.
Wolf, who helped take the company public, has been president of the Hamilton Thorne since 2009 and will continue to hold that role along with the additional CEO responsibilities.
Becton Dickinson and Davita join forces with Waste Management to launch the first U.S. dialyzer recycling pilot in Southern California.
Updated: 8/11/2011 1:15 p.m.
Kidney care services provider DaVita Inc. (NYSE:DVA) is taking on the environmental footprint left by its customers by launching a pilot program to recycle some of the waste from dialysis centers.
Allergan boasts strong sales growth in Q2, but sales are sluggish for its weight-loss gastric banding devices.
Allergan Inc. (NYSE:AGN) touted a strong quarter on the back on growing sales.
The Irvine, Calif.-based company saw strong growth in revenue in the three months ended June 30, posting $1.4 billion in sales, which amounts to a 14 percent increase over $1.2 billion in sales reporting during the same time last year.
Device sales jumped 12 percent to $245 million for the quarter, compared to $219 million in Q2 2010.